Femasys grants director options covering 1,760 shares

The option's stated expiration date is October 30, 2036.

Available on EDGAR 11/05/2026 - 06:12 PM EST Accepted by SEC EDGAR 11/05/2026 - 06:11 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Femasys Inc. director John Hunnewell Moorhead Jr. acquired a stock option covering 1,760 shares of common stock on October 30, 2026, with an exercise price of $1.37 per share. The option vests in equal installments over three years beginning October 30, 2027, assuming continued service.

Insider Trade Summary

Grant/Award: 1,760 shares

Grant/Award 1 txn

Insider Moorhead John Hunnewell Jr

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	1,760	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 1,760 contracts (Direct)

Holdings Before and After: Stock Option (Right to Buy), 0 to 1,760 contracts (Direct)

Footnotes (1)

1. F1. The shares underlying the stock option vest equally in installments over 3 years beginning on October 30, 2027, assuming continued service.

Key Figures

Stock option award: 1,760 options Exercise price: $1.37 per share Vesting period: 3 years +1 more

4 metrics

Stock option award 1,760 options Covers 1,760 shares of common stock; granted October 30, 2026.

Exercise price $1.37 per share Price for the stock option.

Vesting period 3 years Vests in equal installments beginning October 30, 2027, assuming continued service.

Expiration date October 30, 2036 Stated expiration date of the stock option.

Key Terms

stock option, exercise price, vest equally in installments

3 terms

stock option financial

"shares underlying the stock option"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"conversion or exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest equally in installments technical

"vest equally in installments over 3 years"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many FEMY stock options did director John Hunnewell Moorhead Jr. receive?

John Hunnewell Moorhead Jr., a Femasys director, received a stock option covering 1,760 shares of common stock on October 30, 2026. The reported direct option position following the transaction was 1,760 options.

What is the exercise price and expiration date of the FEMY option?

The option has an exercise price of $1.37 per share and expires October 30, 2036.

When do John Hunnewell Moorhead Jr.'s FEMY options vest?

The option vests in equal installments over three years beginning October 30, 2027, assuming continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moorhead John Hunnewell Jr

(Last) (First) (Middle)

C/O FEMASYS INC.

3950 JOHNS CREEK COURT, SUITE 100

(Street)

SUWANEE GEORGIA 30024

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FEMASYS INC [ FEMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.37	10/30/2026		A		1,760		(1)	10/30/2036	Common Stock	1,760	$0	1,760	D

Explanation of Responses:

1. The shares underlying the stock option vest equally in installments over 3 years beginning on October 30, 2027, assuming continued service.

	/s/ Kathy Lee-Sepsick, Attorney-in-fact	11/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)